Control of carboplatin-induced emesis with a fixed low dose of granisetron (0.5 mg) plus dexamethasone

Gynecologic Oncology

Volumn 60, Issue 3, 1996, Pages 435-437

  Markman, Maurie ^a   Kennedy, Alexander ^a   Webster, Kenneth ^a   Kulp, Barbara ^a   Peterson, Gertrude ^a   Belinson, Jerome ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DEXAMETHASONE; GRANISETRON; PACLITAXEL; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG MIXTURE; DRUG SAFETY; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; OVARY CARCINOMA; PERITONEUM CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 0029887761     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0069     Document Type: Article

References (14)

1. Grunberg, S. M., and Hesketh, P. J. Control of chemotherapy-induced emesis, N. Engl. J. Med. 329, 1790-1796 (1993).
2. Calvert, A. H., Harland, S. J., Newell, D. R., Siddik, Z. H., Jones, A. C., McElwain, T. J., Raju, S., Wiltshaw, E., Smith, I. E., Baker, J. M., Peckham, M. M., and Harrap, K. R. Early clinical studies with cis-diammine-1,1 -cyclobutane dicarboxylate platinum(II), Cancer Chemother. Pharmacol. 9, 140-147 (1982).
3. Alberts, D. A., Green, S., Hannigan, E. V., O'Toole, R., Stock-Novack, D., Anderson, P., Surwit, E. A., Malvlya, V. K., Nahhas, W. A., and Jolles, C. J. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages in and IV ovarian cancer, J. Clin. Oncol. 10, 706-717 (1992).
4. Swenerton, K., Jeffrey, J., Stuart, G., Roy, M., Krepart, G., Carmichael, J., Drouin, P., Stanimir, R., O'Connell, G., MacLean, G., Kirk, M. E., Canetta, R., Koski, B., Shelley, W., Zee, B., and Pater, J. Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: A randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group, J. Clin. Oncol. 10, 718-726 (1992).
5. Martin, M., Diaz-Rubio, E., Sanchez, A., Almenarez, J., and Lopez-Vega, J. M. The natural course of emesis after carboplatin treatment, Acta Oncol. 29, 593-595 (1990).
6. Perez, E. A. Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis, J. Clin. Oncol. 13, 1036-1043 (1995).
7. Navari, R., Gandara, D., Hesketh, P., Hall, S., Mailliard, J., Ritter, H., Friedman, C., and Fitts, D., on behalf of the Granisetron Study Group. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis, J. Clin. Oncol. 13, 1242-1248 (1995).
8. Smyth, J. F., Coleman, R. E., Nicolson, M., Gallmeier, W. M., Leonard, R. C. F., Cornbleet, M. A., Allan, S. G., Upadhyaya, B. K., and Bruntsch, U. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? Br. Med. J. 303, 1423-1426 (1991).
9. Hesketh, P. J., Harvey, W. H., Harker, W. G., Beck, T. M., Ryan, T., Bricker, L. J., Kish, J. A., Murphy, W. K., Hainsworth, J. D., Haley, B., Plagge, P., and Flack, N. E. A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis, J. Clin. Oncol. 12, 596-600 (1994).
10. Rose, W. C., and Schurig, J. E. Preclinical antitumor and toxicologic profile of carboplatin, Cancer Treat. Rev. 12(Suppl. A), 1-19 (1985).
11. Harvey, V. J., Evans, B. D., Mitchell, P. L. R., Mak, D., Neave, L. M., Langley, G. B., and Dickson, D. S. P. Reduction of carboplatin induced emesis by ondansetron, Br. J. Cancer 63, 942-944 (1991).
12. Chapman, S. M., and Pruemer, J. M. Ondansetron use in a major university teaching hospital, Am. J. Hosp. Pharm. 50, 670-674 (1993).
13. Peters II, M. D., Long, K. S., Patel, H. S., Reitz, J. A., Jessen, L. M., and Emhart, G. C. Multicenter evaluation of ondansetron use in hospitalized oncology patients, Am. J. Hosp. Pharm. 50, 1164-1170 (1993).
14. Granisetron to prevent vomiting after cancer chemotherapy, Med. Lett. Drugs Ther. 36, 61-64 (1994).